Increased expression of hypoxia-inducible factor 1α in type I and type II endometrial carcinomas
Authors:
Open Access
- 1 January 2007
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 20 (1) , 35-43
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Phosphorylated KDR expression in endometrial cancer cells relates to HIF1α/VEGF pathway and unfavourable prognosisLaboratory Investigation, 2006
- Prognostic significance of erythropoietin expression in human endometrial carcinomaCancer, 2004
- A significance of immunohistochemical determination of steroid receptors, cell proliferation factor Ki-67 and protein p53 in endometrial carcinomaGynecologic Oncology, 2004
- The effect of cyclooxygenase‐2 expression on tumor vascularity in advanced stage ovarian serous carcinomaCancer, 2003
- Significant correlation of hypoxia-inducible factor-1α with treatment outcome in cervical cancer treated with radical radiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2003
- Association of hypoxia‐inducible factors 1α and 2α with activated angiogenic pathways and prognosis in patients with endometrial carcinomaCancer, 2002
- Oxygenation status of malignant tumors: Pathogenesis of hypoxia and significance for tumor therapySeminars in Oncology, 2001
- MIB-1 in Endometrial Carcinoma: Prognostic Significance with 5-Year Follow-UpGynecologic Oncology, 1999
- p53 Expression as a Prognostic Indicator of 5-Year Survival in Endometrial CancerGynecologic Oncology, 1999
- Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension.Proceedings of the National Academy of Sciences, 1995